Repository of University of Nova Gorica

Show document
A+ | A- | Help | SLO | ENG

Title:COVID-19 and the revival of passive immunization: Antibody therapy for inhibiting SARS-CoV-2 and preventing host cell infection: IUPHAR review: 31
Authors:ID Levi-Schaffer, Francesca, University of Jerusalem (Author)
Files: This document has no files that are freely available to the public. This document may have a physical copy in the library of the organization, check the status via COBISS. Link is opened in a new window
Language:English
Work type:Not categorized
Typology:1.02 - Review Article
Organization:UNG - University of Nova Gorica
Keywords:Covid-19, SARS-CoV-2, neutralizing antibodies, passive vaccination
Publication version:Author Accepted Manuscript
Year of publishing:2021
Number of pages:35
Numbering:178
PID:20.500.12556/RUNG-6178 New window
COBISS.SI-ID:45955075 New window
DOI:10.1111/bph.15359 New window
NUK URN:URN:SI:UNG:REP:JDA0N0H8
Publication date in RUNG:07.01.2021
Views:3777
Downloads:0
Metadata:XML DC-XML DC-RDF
:
LEVI-SCHAFFER, Francesca, 2021, COVID-19 and the revival of passive immunization: Antibody therapy for inhibiting SARS-CoV-2 and preventing host cell infection: IUPHAR review: 31. British Journal of Pharmachology [online]. 2021. Vol. 178. [Accessed 22 March 2025]. DOI 10.1111/bph.15359. Retrieved from: https://repozitorij.ung.si/IzpisGradiva.php?lang=eng&id=6178
Copy citation
  
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Searching for similar works...Please wait....
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:British Journal of Pharmachology
Year of publishing:2021

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:07.01.2021

Back